Status:

COMPLETED

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Lead Sponsor:

Rambam Health Care Campus

Conditions:

Knee, Osteoarthritis (OA)

Biomarkers for Prediction of OA Treatment Efficacy

Eligibility:

All Genders

45-75 years

Phase:

NA

Brief Summary

With high NNTs for indiscriminative use in chronic pain, treatment unavoidably entails frustrating long trial and errors. It is timely to identify biomarkers that can predict analgesic efficacy for th...

Detailed Description

Study design: The study design includes two experimental meeting sessions (before and at the end / after the treatment) which include clinical and experimental assessments. After the first experiment...

Eligibility Criteria

Inclusion

  • males and females
  • ages 45 to 75
  • radiographic representation of osteoarthritis of the knee
  • minimal or moderate OA severity, based on the Kellgren and Lawrence system classification (1-3)
  • knee OA pain for more than 3 months, assessed by the patients as being at level 4/10 and above on average at routine daily standing/walking activities during the last week, without medication

Exclusion

  • other more prominent pain
  • previous bilateral total knee replacement (TKR) surgery
  • secondary OA (post-traumatic or post-infectious, osteochondritis dissecans (OCD) and enteropathic arthritis (EA) deformity)
  • significant additional health problems such as substantial painful neuropathy, diabetes above of 5 yrs, renal failure, congestive heart failure, neurological diseases that might mask the pain processing system or reduce patient's cooperation or report capabilities, and significant psychiatric disorders
  • use of opioids or cannabis
  • known diseases of gastrointestinal tract such as esophagitis, gastritis and duodenitis
  • patients that had side effects to the study drugs in the past.

Key Trial Info

Start Date :

December 30 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 8 2024

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT05256342

Start Date

December 30 2021

End Date

April 8 2024

Last Update

April 12 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Rambam Health Care Campus

Haifa, Israel, 31096

2

Rambam Health Care Campus

Haifa, Israel